Data also suggested filgotinib 200mg reduced and eliminated corticosteroid use compared to placebo
News
Almost 50,000 extra doctors needed in England, says BMA
BMA research finds the number of doctors per 1,000 people in England is 25 years behind comparable EU nations
PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups
Vaccine effectiveness against symptomatic disease in at-risk groups is approximately 60% after one dose of either the AZ or Pfizer/BioNTech vaccines
NICE ‘no’ for Orchard Therapeutics’ gene therapy Libmeldy
NICE concluded the cost-effectiveness estimates for Libmeldy are unlikely to be within the range that it would consider an effective use of NHS resources
Valneva’s chikungunya virus vaccine granted breakthrough designation
Currently, no preventative vaccines or effective treatments are available for the chikungunya virus
Expanded access for Zolgensma following final NICE guidance
NHS bodies in Wales and Northern Ireland are now expected to consider providing access to SMA gene therapy
MHRA approves over-the-counter contraceptive pill
First ever contraceptive pill to gain a license for over-the-counter sale in the UK
Survey finds kidney cancer patients face anxiety over delayed scan results
Findings revealed that 66% of patients are waiting at least three weeks after their scan for results
Kuano raises £1m to further develop AI drug discovery platform
Company is aiming to transform the discovery of therapeutics focused on enzyme inhibition
Study finds lower COVID-19 infection prevalence in fully vaccinated people
COVID-19 infection rates were three times lower in fully vaccinated people compared to unvaccinated people
Merck partners with Innervia on bioelectronic therapy development
Collaboration will focus on the development of smart neurostimulators for the treatment of severe chronic diseases
AZ, Amgen’s asthma med tezepelumab gains FDA priority review
Priority review comes following positive results from the Phase III NAVIGATOR trial
Keytruda gains expanded US approval in skin cancer
Checkpoint inhibitor has been approved to treat locally advanced cutaneous squamous cell carcinoma
‘What’s next for patient advocacy?’ Leaders share lessons of Patient Partnership Index 2021 at free virtual event
During the event, the panel explored how partnerships innovated in the face of challenges
Newly introduced Health and Care Bill aims to ‘dispose of unnecessary bureaucracy’
Bill has been formally introduced to Parliament this week
